SQUAWK/NEWS
Account
Account
Menu
Live News EQUITY FLASH M impact

TCRX: Moves to Phase 3

TScan's cancer therapy data supports move to Phase 3 trial

TCRX

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.